首页> 美国卫生研究院文献>Advances in Pharmacological Sciences >A Review on Potential Mechanisms of Terminalia chebula in Alzheimers Disease
【2h】

A Review on Potential Mechanisms of Terminalia chebula in Alzheimers Disease

机译:终末期小脑在阿尔茨海默氏病中的潜在机制研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current management of Alzheimer's disease (AD) focuses on acetylcholinesterase inhibitors (AChEIs) and NMDA receptor antagonists, although outcomes are not completely favorable. Hence, novel agents found in herbal plants are gaining attention as possible therapeutic alternatives. The Terminalia chebula (Family: Combretaceae) is a medicinal plant with a wide spectrum of medicinal properties and is reported to contain various biochemicals such as hydrolysable tannins, phenolic compounds, and flavonoids, so it may prove to be a good therapeutic alternative. In this research, we reviewed published scientific literature found in various databases: PubMed, Science Direct, Scopus, Web of Science, Scirus, and Google Scholar, with the keywords: T. chebula, AD, neuroprotection, medicinal plant, antioxidant, ellagitannin, gallotannin, gallic acid, chebulagic acid, and chebulinic acid. This review shows that T. chebula extracts and its constituents have AChEI and antioxidant and anti-inflammatory effects, all of which are currently relevant to the treatment of Alzheimer's disease.
机译:尽管结果并不完全令人满意,但目前对阿尔茨海默氏病(AD)的治疗重点是乙酰胆碱酯酶抑制剂(AChEIs)和NMDA受体拮抗剂。因此,在草药植物中发现的新型药物作为可能的治疗替代品正受到关注。榄仁(Terminalia chebula)(家族:菊科)是一种药用植物,具有广泛的药用特性,据报道含有多种生物化学物质,如可水解的丹宁酸,酚类化合物和类黄酮,因此可能被证明是一种很好的治疗选择。在这项研究中,我们审查了在以下数据库中找到的已发表的科学文献:PubMed,Science Direct,Scopus,Web of Science,Scirus和Google Scholar,关键字为:T. chebula,AD,神经保护,药用植物,抗氧化剂,鞣花单宁,没食子酸,没食子酸,章鱼酸和草酸。这项审查表明,T。chebula提取物及其成分具有AChEI以及抗氧化剂和抗炎作用,所有这些目前都与阿尔茨海默氏病的治疗有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号